Wal-Mart Charged Premium For Migraine Meds, Suit Says

Law360, New York (September 13, 2013, 4:49 PM EDT) -- Wal-Mart Stores Inc. was hit with a putative class action in New Jersey federal court Thursday alleging it misled consumers into paying twice as much for its store-brand Equate migraine medicine by deceptively marketing it as being more effective than its regular Equate headache medicine.

Plaintiff Bonnie Cooper alleges that both over-the-counter medications contain the same amount of active ingredients and are equally effective in treating migraine headaches, yet Wal-Mart charges consumer twice as much for the migraine version, misleading consumers to think the migraine version...
To view the full article, register now.